Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Vascular Medicine
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Liapis, C. D
Right arrow Articles by Paraskevas, K. I
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liapis, C. D
Right arrow Articles by Paraskevas, K. I
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The pivotal role of matrix metalloproteinases in the development of human abdominal aortic aneurysms

Christos D Liapis

Department of Vascular Surgery, Athens University Medical School, Athens, Greece

Kosmas I Paraskevas

Department of Vascular Surgery, Athens University Medical School, Athens, Greece, paraskevask{at}hotmail.com

Abdominal aortic aneurysms (AAAs) represent a chronic degenerative condition and impart the risk of a life-threatening episode of rupture. Chronic inflammation and destructive remodeling of the extracellular matrix of the aortic wall constitute trademarks of this entity. Multiple studies have implicated a group of locally produced matrix endopeptidases-the matrix metalloproteinases (MMPs)-as the main culprits of this process. For this reason, extensive research on the Identification of the role of these enzymes, as well as possible alternative pharmacological treatments of AAAs, has taken place during the last few years. The exact role of the several members of the group of metalloproteinases has already been discovered, and conservative therapeutic strategies oriented towards these agents have been suggested, but a Definite treatment plan is still a controversial topic. The possible role of a genetic predisposition to AAAs is another crucial topic that remains to be determined, as it would render the confrontation of this condition much more efficient.

Key Words: abdominal aortic aneurysms • matrix metalloproteinases

Vascular Medicine, Vol. 8, No. 4, 267-271 (2003)
DOI: 10.1191/1358863x03vm504ra
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J. Thorac. Cardiovasc. Surg.Home page
J. R. Barbour, R. E. Stroud, A. S. Lowry, L. L. Clark, A. M. Leone, J. A. Jones, F. G. Spinale, and J. S. Ikonomidis
Temporal disparity in the induction of matrix metalloproteinases and tissue inhibitors of metalloproteinases after thoracic aortic aneurysm formation
J. Thorac. Cardiovasc. Surg., October 1, 2006; 132(4): 788 - 795.
[Abstract] [Full Text] [PDF]